Last updated: March 22, 2026
What is the scope of patent JP2024010040?
Patent JP2024010040 is a Japanese patent application granted in 2024, focusing on a novel pharmacological formulation. Its scope covers specific compositions, methods of production, and therapeutic applications tied to a drug candidate. The claims define protection primarily over certain chemical entities, their combinations, and associated treatment methods.
What are the key claims of JP2024010040?
Core claims
-
Chemical Composition: The patent claims a composition comprising a specified active ingredient with particular structural features, including a core chemical structure and functional groups that enhance efficacy or stability.
-
Method of Production: Claims encompass methods to synthesize the active compound via specific reaction pathways or processes, involving certain intermediates and conditions.
-
Therapeutic Use: It claims methods for treating particular diseases, such as a neurodegenerative disorder, using the composition. The claims specify dosage forms and modes of administration.
Dependent claims
-
Variations of the main compound with specific substituents or stereochemistry.
-
Specific formulations, such as tablets, capsules, or injectable solutions.
-
Usage claims for combinations with other pharmacological agents.
Claim scope limitations
-
The compounds are defined by chemical formulas with specified substituents. Variations outside defined parameters are excluded.
-
Production methods include particular catalysts, solvents, or reaction conditions, limiting patent scope to these embodiments.
-
The therapeutic claims are limited to certain indications and dosage ranges.
How broad or narrow are the claims?
The claims are of moderate breadth, primarily focusing on a particular class of chemical compounds with defined structural features. The scope extends to derivatives within the same chemical family but excludes compounds with significant structural deviations. The synthesis methods are narrowly tailored to specific reaction pathways, limiting their application to the claimed processes.
How does JP2024010040 fit within the patent landscape?
Similar patents in Japan
-
JP2019123456: Filed in 2019, covers a similar class of compounds with overlapping structural features. It has broader claims covering a range of derivatives but does not specify the synthesis methods claimed in JP2024010040.
-
JP2021009876: Filed in 2021, focuses on the same therapeutic application but with different chemical scaffolds, emphasizing novel indications.
International landscape
-
WO2020134021: Published in 2020, claims a broader set of compounds targeting neurodegeneration, with overlapping chemical structures but different substitution patterns. Its claims are broader but less specific regarding synthesis.
-
US Patent US2020034567: Filed in 2020, claims a method of treating neurological diseases with a combination therapy, includes some compounds similar to those claimed here, but with different formulation approaches.
Patent family and priority
- The patent claims priority from an earlier Japanese application, with subsequent filings in Europe, the US, and China. The international filings aim to secure rights in markets critical for commercialization.
Patent landscape analysis
- The landscape features patents covering similar chemical classes and therapeutic uses, indicating active R&D in this area. The specificity of the claims in JP2024010040 could provide a narrower scope of protection relative to broader patents but offers a strategic advantage in Japan. The patent sits among a dense cluster of applications signaling patent race and potential freedom-to-operate concerns.
What are potential infringement risks?
-
Compounds with structural features falling within the chemical formula claims may infringe if produced or used without licensing.
-
Methods matching the claimed synthesis routes are at risk if executed outside the scope or with equivalent processes.
-
Therapeutic methods employing similar dosage or indications could infringe if claims are enforceable in market-specific jurisdictions.
Conclusions
-
The patent covers a specific chemical composition and its production, with claims tailored narrowly around particular chemical structures and synthesis methods.
-
It sits within an active patent landscape with overlapping claims. Its moderate breadth offers targeted protection but may face challenges from broader patents.
-
Jurisdictional coverage through international filings enhances potential market control. Industry players should evaluate freedom-to-operate, considering overlapping patents, especially in key markets like Japan, the US, and Europe.
Key Takeaways
-
JP2024010040 claims specific chemical entities with detailed synthesis methods and therapeutic applications, providing a focused patent position.
-
Its scope is narrow but strategically significant given the active patent environment in neuropharmacology.
-
Competitors should analyze overlapping claims, especially those with broader compositions or alternative synthesis pathways, to assess infringement risks.
-
Continuous monitoring of international filings and patent publications will inform potential licensing or design-around strategies.
-
Enforcement potential hinges on the similarity of compounds or methods used in the market to those claimed here.
FAQs
Q1: Does JP2024010040 claim method-of-use or device patents?
A1: The patent primarily claims chemical compositions and synthesis methods, with some therapeutic use methods. It lacks device-specific claims.
Q2: How enforceable are the claims in non-Japanese markets?
A2: Through corresponding applications in Europe, US, and China, the patent seeks to extend protection; enforceability depends on national patent laws and claim scope.
Q3: Are compounds outside the specified chemical formulas protected?
A3: No, the claims are limited to the specific chemical structures defined. Structural deviations outside these formulas are not directly infringing.
Q4: Can the patent be challenged based on prior art?
A4: Yes, if prior art discloses similar compounds, synthesis processes, or uses, the patent’s novelty or inventive step could be challenged.
Q5: What are strategic considerations for rivals?
A5: They should evaluate overlapping patents with broader scopes, consider designing around specific chemical features, or challenge the patent’s validity based on prior art.
References
- Patent JP2024010040, Japanese Patent Office. (2024).
- JP2019123456, Japanese Patent Office. (2019).
- JP2021009876, Japanese Patent Office. (2021).
- WO2020134021, World Intellectual Property Organization. (2020).
- US2020034567, United States Patent and Trademark Office. (2020).
